Heading back into CNS

Best known for its work in oncology and immunology, Genentech Inc. has decided to have another go at neurological diseases with last week's deal to license a preclinical antibody program for Alzheimer's disease from AC Immune Ltd.

Genentech (DNA, South San Francisco, Calif.) has done

Read the full 454 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE